This recent longitudinal study investigated patterns of sun protective behaviours in Western Australian adolescents and adults over a six-year period.
This recent study investigated the impact of time of adjuvant immunotherapy on survival in patients with stage III melanoma.
This recent study attempted to validate the Melanoma Institute of Australia's Sentinel Node Metastasis Risk Prediction Tool using the National Cancer Database.
This recent study sought to determine whether histologic margin status is an independent predictor of progression for lentigo maligna melanomas.
The PROVE-AI study looks to validate the accuracy of an open-source, non-commercial AI algorithm for melanoma diagnosis and assess its potential impact on dermatologist decision-making.
This recent study sought to determine the mechanisms underlying radioresistance in melanoma cell lines in order to improve clinical efficacy of radiation therapy.
This recent study looked at long-term outcomes for stage III/IV melanoma patients treated with neoadjuvant and adjuvant PD-1 inhibition. Five-year results demonstrated long-term efficacy of single-agent neoadjuvant/adjuvant PD-1 blockade in patients with a complete pathological response and the importance of long-term follow-up for these patients.
This study examined the association between SMARCD1 expression and numerous factors in order to demonstrate that SMARCD1 is a promising diagnostic, prognostic, and therapeutic biomarker for skin cutaneous melanoma.
This recent study demonstrated that lactate dehydrogenase has independent prognostic value for patients with melanoma brain metastases and might be used to improve prognostic stratification.
This study sought to construct a usable matrix of ultra violet radiation exposure across 250 occupations based on data obtained from 1000 individuals who wore electronic data logger dosimeters during their working time over a 7-month period. Information from the detailed datasets may be extrapolated for use in other countries, including NZ to aid in identifying high-risk occupational activity.